|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhao J, Mao Z, Fedewa SA, Nogueira L,
Yabroff KR, Jemal A and Han X: The affordable care act and access
to care across the cancer control continuum: A review at 10 years.
CA Cancer J Clin. 70:165–181. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
DeSantis CE, Ma J, Gaudet MM, Newman LA,
Miller KD, Goding Sauer A, Jemal A and Siegel RL: Breast cancer
statistics, 2019. CA Cancer J Clin. 69:438–451. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Schnitt SJ: The diagnosis and management
of pre-invasive breast disease: Flat epithelial atypia -
classification, pathologic features and clinical significance.
Breast Cancer Res. 5:263–268. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Batista PJ and Chang HY: Long noncoding
RNAs: Cellular address codes in development and disease. Cell.
152:1298–1307. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hauptman N and Glavač D: Long non-coding
RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bao Z, Yang Z, Huang Z, Zhou Y, Cui Q and
Dong D: LncRNADisease 2.0: An updated database of long non-coding
RNA-associated diseases. Nucleic Acids Res. 47 (D1):D1034–D1037.
2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Han S, Cao D, Sha J, Zhu X and Chen D:
LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by
interacting with UPF1 to destabilize ZFPM2. Mol Oncol.
14:1074–1088. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhao M, Xin XF, Zhang JY, Dai W, Lv TF and
Song Y: LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by
regulating miR-96-5p/CYLD signaling. Cancer Med. 9:1196–1208.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Han L, Kong R, Yin DD, Zhang EB, Xu TP, De
W and Shu YQ: Low expression of long noncoding RNA GAS6-AS1
predicts a poor prognosis in patients with NSCLC. Med Oncol.
30(694)2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yang S, Liu T, Sun Y and Liang X: The long
noncoding RNA LINC00483 promotes lung adenocarcinoma progression by
sponging miR-204-3p. Cell Mol Biol Lett. 24(70)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Luo Z, Han Z, Shou F, Li Y and Chen Y:
LINC00958 accelerates cell proliferation and migration in non-small
cell lung cancer through JNK/c-JUN signaling. Hum Gene Ther
Methods. 30:226–234. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li W, Zhang B, Jia Y, Shi H, Wang H, Guo Q
and Li H: LncRNA LOXL1-AS1 regulates the tumorigenesis and
development of lung adenocarcinoma through sponging miR-423-5p and
targeting MYBL2. Cancer Med. 9:689–699. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ai J, Sun J, Zhou G, Zhu T and Jing L:
Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585,
thereby increasing EIF5A2 expression and facilitating
hepatocellular carcinoma oncogenicity. Cell Cycle. 19:742–757.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gao JB, Zhu MN and Zhu XL: miRNA-215-5p
suppresses the aggressiveness of breast cancer cells by targeting
Sox9. FEBS Open Bio. 9:1957–1967. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Liu X, Song J, Kang Y, Wang Y and Chen A:
Long noncoding RNA SOX21-AS1 regulates the progression of
triple-negative breast cancer through regulation of
miR-520a-5p/ORMDL3 axis. J Cell Biochem. 121:4601–4611.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chu F, Xue L and Miao H: Long noncoding
RNA TP73-AS1 in human cancers. Clin Chim Acta. 500:104–108.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gourvest M, Brousset P and Bousquet M:
Long noncoding RNAs in acute myeloid leukemia: Functional
characterization and clinical relevance. Cancers (Basel).
11(E1638)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jeselsohn R, Cornwell M, Pun M, Buchwalter
G, Nguyen M, Bango C, Huang Y, Kuang Y, Paweletz C, Fu X, et al:
Embryonic transcription factor SOX9 drives breast cancer endocrine
resistance. Proc Natl Acad Sci USA. 114:E4482–E4491.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Jana S, Madhu Krishna B, Singhal J, Horne
D, Awasthi S, Salgia R and Singhal SS: SOX9: The master regulator
of cell fate in breast cancer. Biochem Pharmacol.
174(113789)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhao Y, Pang W, Yang N, Hao L and Wang L:
MicroRNA-511 inhibits malignant behaviors of breast cancer by
directly targeting SOX9 and regulating the PI3K/Akt pathway. Int J
Oncol. 53:2715–2726. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fazilaty H, Gardaneh M, Akbari P, Zekri A
and Behnam B: SLUG and SOX9 cooperatively regulate tumor initiating
niche factors in breast cancer. Cancer Microenviron. 9:71–74.
2016.PubMed/NCBI View Article : Google Scholar
|
